Introduction
Over the past several decades, risk factors for atherosclerotic disease have been identified in epidemiological and experimental studies 1) . Because several risk demiological Study of Subclinical Atherosclerosis (SESSA). Of these men, 1,096 agreed to participate. The population of 40-to 79-year-old men in Kusatsu city was 25,394 in April 2005. Therefore, the extraction rate was 9.4% (2,381/25,394), and the participation rate in this survey was 46% (1,096/2,381) for men. Among these participants, 868 men 40 to 74 years of age without a history of cardiovascular disease who underwent carotid ultrasound examinations were analyzed. The Institutional Review Board of Shiga University of Medical Science approved this study (17) (18) (19) .
Study Examinations
Trained observers collected data regarding smoking, alcohol consumption and medical history using a self-administered questionnaire and physical measurements. The body mass index (BMI) was calculated as the weight (kg) divided by the square of the height (m). Blood pressure was measured using an automatic blood pressure measurement machine placed on the right arm of the seated participant after a five-minute rest. The ankle-brachial index (ABI) was estimated by measuring the blood pressure of the brachial and tibial arteries using an automatic measurement machine (Form PWV/ABI, Omron Colin, Japan) with the participant in the supine position after a five-minute rest. Peripheral artery disease (PAD) was defined as an ABI of ＜0.9 on either side.
Fasting blood samples were obtained. The serum was separated and centrifuged soon after blood coagulation. Plasma samples were collected in siliconized tubes and shipped to a laboratory (Shiga Laboratory; MEDIC, Japan) for the blood measurements. The levels of serum triglycerides (TGs) and total cholesterol were measured enzymatically, and that of high-density lipoprotein (HDL) cholesterol was measured after heparin-calcium precipitation. The measurements were standardized according to the Centers for Disease Control and Prevention/US Collaborating Center for Reference Method Laboratory Network Research in Blood Lipids (CDC/CRMLN) 12) . Hypo-HDL cholesterolemia was defined as an HDL cholesterol level of ＜40 mg/dL. Plasma was collected into siliconized tubes containing sodium fluoride for the enzymatic glucose measurements. The level of hemoglobin A1c (HbA1c) was measured using a latex agglutination inhibition assay according to the standardized method of the Japan Diabetes Society (JDS) and converted into the National Glycohemoglobin Standardization Program (NGSP) value using the following formula: HbA1c (NGSP) (%) = 1.02×HbA1c (JDS) (%)＋0.25 13) . In the present study, diabetes mellitus was defined as a factors frequently coexist in a single individual, the risk of atherosclerosis is preferentially assessed from a global viewpoint employing an absolute risk assessment that includes multiple risk factors 2) . Several institutes, including the European Society of Cardiology and European Atherosclerosis Society (ESC/EAS) and the National Cholesterol Education ProgramAdult Treatment Panel Ⅲ (NCEP-ATPⅢ), have proposed guidelines using risk charts to estimate the absolute risk [3] [4] [5] . In 2012, the Japan Atherosclerosis Society proposed comprehensive lipid and risk management guidelines (JAS guidelines 2012) using the NIPPON DATA80 Risk Assessment Chart to estimate the 10-year absolute risk of coronary artery disease (CAD) death and stratified individuals into three categories for the primary prevention of CAD . Therefore, the degree of subclinical atherosclerosis in the general population based on the new guideline categories should be clarified. Furthermore, the JAS guidelines 2012 classify individuals with diabetes mellitus into Category Ⅲ, although diabetes mellitus is considered to be a more severe condition requiring secondary prevention, according to the NCEP-ATPⅢ 4, 5) . In the new guidelines, individuals with chronic kidney disease (CKD) are also classified into Category Ⅲ. Therefore, the appropriateness of including diabetes mellitus and CKD in Category Ⅲ for Japanese individuals should also be clarified.
The degree of carotid atherosclerosis can be assessed noninvasively using ultrasonography. Several studies have reported a relationship between cardiovascular disease (CVD) and the intima media thickness (IMT) and plaque number [7] [8] [9] [10] [11] . We herein investigated whether the degree of subclinical atherosclerosis of the carotid arteries in the general population today is concordant with the categories in the JAS guidelines 2012 and the estimated 10-year absolute risk of CAD death.
Methods

Study Population
Between 2006 and 2008, 2,381 Japanese men 40 to 79 years of age were randomly selected based on age strata from Kusatsu City, Japan and sent an invitation to participate in the baseline survey of the Shiga Epi-eGFR of ＜60 mL/min/1.73 m 2 . The IMT and number of plaques from the common carotid artery (CCA) to the internal carotid artery (ICA) were investigated using an ultrasound device equipped with a 7.5-MHz probe (Xario-660A, Toshiba Medical Systems, Japan) according to a standardized method established and certified by the Ultrasound Research Laboratory of University of Pittsburgh. The details of the scanning procedure have been described elsewhere 7, 14, 15) . In brief, for the CCA, both the far and near wall 1 cm proximal to the bulb were examined, while only the far wall was examined with respect to the bulb and a 1-cm area of the internal carotid artery (ICA). The IMT was traced using the automatic image reading program of the AMS (Chalmers University of Technology, Gotenburg, Sweden). A plaque was defined as a focal thickening lesion with an IMT of ≥ 1 mm. fasting blood glucose level of ≥ 126 mg/dL and/or an HbA1c (NGSP) level of ≥ 6.5% and/or the use of antidiabetic medications, although diabetes mellitus is defined as a casual blood glucose level of ≥ 200 mg/dL in the original NIPPON DATA80 Risk Chart. Impaired glucose tolerance was defined as a fasting glucose level between 110 mg/dL and 126 mg/dL for only those individuals not taking medications for diabetes mellitus. The serum creatinine level was measured enzymatically. The estimated glomerular filtration rate (eGFR) was calculated using the following formula for men: eGFR (mL/min/1.73 m 2 ) = 194× creatinine −1.094 ×age −0.287 . Casual urine was collected for the semiquantitative assessment of proteinuria using a dipstick (Uriace-kc, Terumo, Japan). The results were recorded as (−), (±), (＋), (2＋), (3＋) or (4＋), which corresponded to approximate protein concentrations of ＜15, ＜30, ＜100, ＜250, ＜1,000 and ≥ 1,000 (mg/dL), respectively. Chronic kidney disease (CKD) was defined as proteinuria ≥ (＋) and/or an This flow chart is not applicable to patients with FH. ＊ Non-cardiogenic cerebral infarction was excluded as history of stroke for the present study. ＊ ＊ Family history of premature CAD was not considered for the present study. LDL-cholesterol: low density lipoprotein cholesterol HDL-cholesterol: high density lipoprotein cholesterol guidelines 2012, and the participants were classified into three categories: "Category Ⅰ" (an estimated absolute risk of ＜0.5%), "Category Ⅱ" (0.5% to ＜2.0%) and "Category Ⅲ" (≥ 2.0%). The presence of any of the following risk factors ("additional risk factors") resulted in an upgrade from Category Ⅰ or Ⅱ to Category Ⅱ or Ⅲ, respectively: hypo-HDL cholesterolemia, a family history of premature CAD and/or impaired glucose tolerance. In the present analysis, we categorized the participants similarly, with two exceptions:
(1) none of the study participants had a history of noncardiogenic cerebral infarction because a history of any type of stroke was an exclusion criterion for the cohort; (2) a family history of premature CAD was not assessed because we did not obtain the pertinent information. In the subanalyses, we further stratified the participants in Category Ⅲ according to the presence or absence of diabetes mellitus and CKD to compare the carotid ultrasonography findings between these groups. We also analyzed the participants using stratification according to the median age (＜63 years
Categorization of the Participants and Estimation of the 10-Year Absolute Risk of CAD Death
First, we estimated the 10-year absolute risk of CAD using the original NIPPON DATA80 Risk Chart based on the baseline age (years), sex, current smoking status (yes/no), systolic blood pressure (mmHg), total cholesterol level (mg/dL) and presence of diabetes mellitus (yes/no) 6) . Next, we classified the participants into the three categories proposed by the JAS guidelines 2012 for the purpose of LDL-c management: "Category Ⅰ" (low risk), "Category Ⅱ" (intermediate risk) and "Category Ⅲ" (high risk) 5) . The classification steps are shown in Fig. 1 . According to the guidelines, in the first step, individuals with either DM, CKD, a history of noncardiogenic cerebral infarction or PAD were per se considered to be at high risk for CAD death, with a rate equivalent to ≥ 2% within 10 years, and were classified into Category Ⅲ without any further risk assessment. In the second step, the 10-year absolute risk of CAD death was estimated using the methods of the JAS CAD: coronary artery disease, BMI: body mass index, HDL-cholesterol: high density lipoprotein cholesterol, eGFR: estimated glomeruler filtration rate bers in the carotid artery according to the estimated 10-year absolute risk of CAD death assessed using the original NIPPON DATA80 Risk Chart. The mean IMT of the CCA, ICA and bulb all increased in association with an increase in the estimated 10-year absolute risk. The number of plaques also increased from one for an estimated 10-year absolute risk of ＜0.5% to up to four for a risk of ≥ 5%. All of these trends were statistically significant among the four categories of estimated 10-year absolute risk (p for trend ＜0.001).
Table 3 (A) shows the IMT values and plaque numbers according to the categories described in the JAS guidelines 2012. The IMT and plaque number increased in association with the category number. Among the category Ⅲ participants, the mean IMT values at all sites were higher, the prevalence of plaque was as high as 83% and the mean number of plaques was three. We further stratified the participants in category Ⅲ according to the presence or absence of diabetes mellitus (Table 3 (B) ). The mean IMT and plaque number in the participants with diabetes mellitus were similar to those of the nondiabetic category Ⅲ participants. The prevalence of a CCA IMT of ＞1.0 mm was significantly higher among the participants with diabetes mellitus; however, when we estimated the prevalence of a CCA IMT ＞1.1 mm, no statistically significant differences were found (5.2% in the nondiabetic participants, 7.1% in the participants with diabetes mellitus, p for the difference was 0.421) (not shown in the table). Table 3 (C) shows the presence of carotid atherosclerosis in the category Ⅲ participants stratified according to the presence or absence of CKD. There were no statistical differences between the participants with and without CKD.
(mean±SD: 54.4±6.9), ≥ 63 years (mean±SD: 68.9±3.7)) because carotid atherosclerosis is strongly associated with age, which is a classification factor in this category.
Statistical Methods
Differences in the characteristics of the participants were examined using an analysis of variance for continuous variables and the χ 2 -test for dichotomized variables according to the estimated absolute risk. All confidence intervals (CIs) were estimated at the 95% level. A p-value of ＜0.05 was considered to be statistically significant. The Statistical Package for the Social Sciences, version 17.0J software program (SPSS Japan Inc., Tokyo, Japan) was used for all analyses. Table 1 shows the characteristics of the study participants according to the estimated 10-year absolute risk of CAD death. The mean age of the participants was higher and the levels of traditional atherosclerotic risk factors, such as blood pressure, lipids and glucose, were less favorable among the participants with a higher 10-year absolute risk. Conversely, current drinkers were more frequent among those with a lower risk. The prevalence of current smokers tended to be higher in the lower risk groups; however, the value of the lowest risk group was 37.8%, which is similar to the value of the highest risk group (38.3%). The proportion of participants with a 10-year absolute risk of CAD death ≥ 2% was 36.7% among the present study population. Table 2 shows the IMT values and plaque num- future risk of cardiovascular events, including stroke and CAD [7] [8] [9] [10] [11] [16] [17] [18] [19] . In Japan, Kitamura et al. reported that an increased IMT of the CCA and the presence of uncalcified plaque in the ICA predict the risk of stroke in the general elderly population 11) . The reported value of the relative risk of an increased IMT varies with respect to different study participants and end points 18, 19) . A systematic review and meta-analysis of cohort studies in Western countries concluded that the relative risk per IMT difference is slightly higher for stroke than for CAD 20) . However, most risk factors, even those for stroke, are common to both the coronary and carotid arteries, although the impact of each risk factor can differ. Therefore, the results of the present study showing that the presence of carotid atherosclerosis is concordant with the estimated 10-year absolute risk of CAD are acceptable.
Results
The NIPPON DATA is a cohort study of participants of the National Survey on Circulatory Disorders of Japan conducted by the Ministry of Health, Labour and Welfare of Japan 6, [21] [22] [23] [24] . The baseline data of the NIPPON DATA80 were obtained in 1980, more than 30 years ago. Since then, the lifestyle and Similar results were also observed with respect to stratification according to the median age (＜63 years (mean±SD: 54.4±6.9), ≥ 63 years (mean±SD: 68.9 ±3.7)) ( Table 4) . We also performed a sensitivity analysis restricted to the participants not taking medications for hypertension, dyslipidemia or diabetes mellitus. The mean IMT and number of plaques were similar to the results shown in Table 3 (data not shown).
Discussion
We found that the mean carotid IMT and plaque number are concordant with the risk stratification of the lipid management guidelines proposed by the JAS guidelines 2012, estimating the 10-year absolute risk of CAD death using the NIPPON DATA80 Risk Assessment Chart. To the best of our knowledge, this is the first report to clarify carotid ultrasonography findings according to the absolute risk of CAD in the general population, especially in Asia, where stroke is the predominant cause of CVD mortality.
Previous studies have demonstrated that the IMT and the presence of carotid plaque are associated with diabetes mellitus into Category Ⅲ for primary prevention, not the category of secondary prevention. Furthermore, the guidelines recommend that the LDL-C level in diabetic individuals be ＜120 mg/dL 5) . In the present study, we compared the participants with diabetes mellitus and those without diabetes in Category Ⅲ separately and found that the carotid ultrasonography findings were similar between the two groups. Our findings therefore support the JAS guidelines 2012, which place diabetes mellitus into Category Ⅲ. However, we also found that the prevalence of plaque tended to be higher among the participants with diabetes mellitus than those without. Our study participants were by and large relatively healthy individuals from the general population and did not include severely diabetic patients with poor glycemic control. Therefore, further studies are needed to clarify the target lipid levels in Japanese patients with diabetes mellitus.
Previous epidemiological studies have demonstrated that CKD is a high risk factor for CVD [38] [39] [40] . Therefore, the JAS guidelines 2012 classify individuals with CKD into Category Ⅲ for primary prevention and recommend a target level of LDL-C of ＜120 mg/ dL 5) . In the present study, we confirmed that the degree of carotid atherosclerosis in the participants with CKD was as severe as that observed in the participants in Category Ⅲ without CKD, which supports the classification of the guidelines.
Several limitations regarding the present study should be noted. First, family history was not considered during risk classification in this study. Second, we conducted this study in men only; thus, the results may not be applicable to women. Finally, we used the IMT as a surrogate marker of subclinical atherosclerosis, although the predictive value of the progression of IMT is in debate 41) . Further studies using CAD as a study end point are required to confirm the validity of the guidelines.
In conclusion, the carotid IMT and prevalence of plaque, as assessed using ultrasonography, are concordant with the risk stratification described in the lipid and comprehensive risk management guidelines proposed by the JAS guidelines 2012. Individuals classified as belonging to the higher category should adequately control their risk factors, including the lipid levels, with lifestyle modification and medications in order to prevent CVD. . Nevertheless, our findings regarding carotid atherosclerosis in the present population are concordant with the estimated 10-year absolute risk and the categories described in the JAS guidelines 2012.
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